Last reviewed · How we verify

NCT03719807: PARIS

Protocol of Accelerated Rehabilitation Following Surgical Correction of Adolescent Idiopathic Scoliosis

Completed NA Last updated 13 September 2023
What this trial tests

NA trial testing Rehabilitation protocol in Scoliosis Idiopathic in 23 participants. Completed in 30 November 2022.

Timeline
1 December 2018
Primary endpoint
30 November 2022
30 November 2022

Quick facts

Lead sponsorThe Royal Orthopaedic Hospital NHS Trust
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment23
Start date1 December 2018
Primary completion30 November 2022
Estimated completion30 November 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

The Royal Orthopaedic Hospital NHS Trust

Who can join

Adults 11 to 18, any sex, with Scoliosis Idiopathic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to identify whether an accelerated physiotherapy led rehabilitation programme for adolescents undergoing idiopathic scoliosis correction surgery can be delivered safely and effectively post-operatively, and whether it might improve activity levels and quality of life outcomes for the study group. This research is being conducted as previous research indicates that up to 41% of patients who have surgical correction of their scoliosis either return to athletic activity at a lower level than before, or they do not return to athletic activity at all. This is despite significant advancement in the instrumentation being used in recent years which makes the corrections more stable and robust. Some studies have shown that surgically treated AIS patients have significantly reduced physical function and quality of life scores, and that this could be improved with exercise. So far no trials have investigated whether post-operative rehabilitation can improve quality of life for these patients. The initial study will be a pilot study, comprising of 20 participants in a small, pragmatic randomised controlled trial (RCT). It will be conducted at The Royal Orthopaedic Hospital, a specialist National Health Service (NHS) orthopaedic centre. Adolescents (between 11-18 years of age) who have a diagnosis of adolescent idiopathic scoliosis (AIS) and are on the waiting list for surgical correction of this scoliosis will be included. The study will compare a post-operative accelerated rehabilitation programme (commenced at 6 weeks post surgery) with usual care and investigate if the accelerated intervention can be delivered safely and effectively after this procedure. Following surgery, both groups will have the same inpatient rehabilitation up until the point of discharge home. The intervention group will then complete 12 sessions of physiotherapy as an outpatient, which starts at 6 week post-op. The usual care group will not have any further physiotherapy, in line with current standard practice at this centre. Both groups will be assessed using patient reported outcome measures pre-operatively, and at 6 months and 12 months post-operatively, to assess function and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Protocol of Accelerated Rehabilitation following surgery for adolescent Idiopathic Scoliosis (PARIS) : a feasibility study.
    Walters J, Stephens G, Gardner A. · · 2025 · PMID 40935367 · DOI 10.1302/2633-1462.69.bjo-2025-0012.r1

Verify or expand the search:

Other trials of Rehabilitation protocol

Trials testing the same drug.

Other recruiting trials for Scoliosis Idiopathic

Currently open trials in the same condition.

Other The Royal Orthopaedic Hospital NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03719807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing